Physician profile
Anupama Nutakki
NPI 1386605657
$1,122.83
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $425 · 2021: $553 · 2022: $145.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $235.93 | 2020-2022 | |
| Astellas Pharma US INC | $152.55 | 2021-2022 | |
| Amgen INC. | $141.39 | 2020-2022 | |
| Lilly USA, LLC | $88.64 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.26 | 2020-2021 | |
| Abbvie INC. | $58.09 | 2021 | |
| Sunovion Pharmaceuticals INC. | $38.89 | 2020 | |
| Boston Scientific Corporation | $36.93 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $30.83 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.93 | 2020-2022 | |
| Pfizer INC. | $28.22 | 2020-2021 | |
| Amarin Pharma, INC. | $27.16 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $21.23 | 2020 | |
| Xeris Pharmaceuticals, INC. | $18.26 | 2022 | |
| Dexcom, INC. | $17.42 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.23 | 2022 | |
| Merck Sharp & Dohme LLC | $17.01 | 2020 | |
| Nevro Corp. | $14.13 | 2021 | |
| Abbott Laboratories | $14.13 | 2021 | |
| Hologic Sales and Service, LLC | $13.83 | 2020 | |
| Stryker Corporation | $12.86 | 2020 | |
| Mylan Specialty L.P. | $12.80 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupama Nutakki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.